Rhabdomyosarcoma with TFCP2 rearrangement (TFCP2-RMS) is a newly described bone sarcoma characterised by the fusion of TFCP2 to either EWSR1 or FUS showing a remarkable predilection for the craniofacial bones, mainly the mandible and the maxilla (33). Here, TFCP2 is linked to bone sarcoma.